Greenstone Biosciences is a drug discovery platform that accelerates the development of effective therapies for patients.
Greenstone Biosciences has raised $2.8M in total funding. The most recent round was Grant. The last funding was announced in September 2023.
Greenstone Biosciences's investors include National Institutes of Health, California Institute for Regenerative Medicine.
Greenstone Biosciences is headquartered in Palo Alto, United States.
Greenstone Biosciences is a drug discovery platform that accelerates the development of effective therapies for patients.
Greenstone Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Greenstone Biosciences — Funding & Investors." VCBacked, September 13, 2023, https://www.vcbacked.co/company/greenstone-biosciences. Accessed October 30, 2026.
VCBacked. (2023). Greenstone Biosciences — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/greenstone-biosciences
{{cite web |title=Greenstone Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/greenstone-biosciences |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated